Pluri Inc.
PLUR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001158780
No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Pluri Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 21 | 19 | −2 |
| Shares | 77.1K | 52.3K | −24.8K (−32.1%) |
| Value | $382.0K | $234.9K | −$147.1K (−38.5%) |
New holders (2)
Institutions that held Pluri Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Quent Capital, LLC | 57 | $255 | 0.00% |
| Huntington National Bank | 38 | $170 | 0.00% |
Sold out (4)
Institutions that held Pluri Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 25,438 | $125.9K |
| Raymond James Financial Inc | 4,930 | $24.4K |
| Citigroup Inc | 712 | $3.52K |
| CBIZ Investment Advisory Services, LLC | 7 | $35 |